About Bilal Yousufzai, M.D.

Licensed to practice medicine in the state of Georgia

Best Poster Award, Washington Retina Symposium, 2015

Georgetown University Hospital SPIRIT Award, 2015

Alpha Omega Alpha Honor Medical Society, 2012

Phi Beta Kappa, 2008

Alpha Epsilon Delta Health Professional Honor Society, 2007

University of Georgia Henry King Stanford Scholarship, merit scholarship, 2005-09

Vitreoretinal Surgery Fellow at Associates in Ophthalmology Ltd; West Mifflin, Pennsylvania; July 2017-June 2019

Residency in Ophthalmology, Chief Resident PGY-4, at Georgetown University and Washington Hospital Center; Washington, D.C.; July 2014-June 2017

Preliminary Intern Post-Graduate Year 1, Internal Medicine at the Medical College of Georgia; Augusta, Georgia; July 2013-June 2014

M.D. from the Medical College of Georgia; Augusta, Georgia; May 2013

Bachelor’s Degrees in Economics and Microbiology from the University of Georgia; Athens, Georgia; Magna Cum Laude with High Honors; May 2009

American Academy of Ophthalmology

American Society of Retina Specialists

Association for Research in Vision and Ophthalmology

Principal Investigator, August 2019 — A Multicenter, Double-Masked, Randomized, Dose-Ranging, Trial to Evaluate the Efficacy and Safety of Conbercept Intravitreal Injection in Subjects with Neovascular Age-related Macular Degeneration, Sponsored by Chengdu Kanghong Biotech Co., Ltd (PANDA)

Sub-Investigator, May 2018 — A Randomized, Masked, Controlled Trial to Study the Safety and Efficacy of Suprachoroidal CLS-TA in Combination with an Intravitreal Anti-VEGF Agent in Subjects with Retinal Vein Occlusion, Sponsored by Clearside Biomedical (TOPAZ)

Sub-Investigator, November 2017 — A Phase 2b Randomized, Double-Masked, Controlled Trial to Assess the Safety and Efficacy of Intravitreous Administration of Zimura™ (Anti-C5 Aptamer) in Subjects With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration, Sponsored by Ophthotech (OPH2003)

Sub-Investigator, July 2017 — Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension (CLS-TA) in Patients With Non-Infectious Uveitis, Sponsored by Clearside Biomedical (AZALEA)

Clinical Investigator, July 2017-Present — Comparison of the Rous Needle Subtenon’s Block versus Standard Retrobulbar Block Approach in Retina Surgery — Principal Investigator: Miguel Busquets, M.D.

Clinical Investigator, Dec 2015-June 2017 — Anterior Segment Findings in Patients with Blast Induced Traumatic Brain Injury — Principal Investigator: Teresa Magone, M.D.

Clinical Investigator, July 2015-June 2017 — Understanding Patient Understanding: Evaluating Glaucoma Medication Compliance in an Urban Hospital Patient Population — Principal Investigator: Rosan Choi, M.D.

Clinical Investigator, Nov 2014-June 2017 — Retinal Vein Occlusion in Young Patients: Assessing Visual Outcomes and Risk Factors — Principal Investigator: Michael Lai, M.D., Ph.D.

Medical Student Research Assistant, July 2012 — Cognitive Rehabilitation of Neuro-ophthalmological Deficits Using the Neuroscientific Principles of Ambiguity Reduction — Principal Investigator: Jay Hegde, Ph.D.

Medical College of Georgia Vision Discovery Institute Fellowship, May-July 2010 — Role of proNGF in Glial Activation and Neuronal Death in Diabetic Retinopathy — Principal Investigator: Azza El-Remessy, Ph.D.

Student Training and Research Program Fellowship, May-July 2007 — Mechanism for Anti-Inflammatory Effects of Cannabidiol in Diabetic Retinopathy — Principal Investigator: Gregory Liou, Ph.D.

Publications

Whitmire, W.; Al-Gayyar, M.M.; Abdelsaid, Y.; Yousufzai, B.K.; El-Remessy, A.B. Alteration of Growth Factors and Neuronal Death in Diabetic Retinopathy: What We Have Learned So Far. Molecular Vision.2011;17:300–308.

Liou, G.I.; Auchampach, J.A.; Hillard, C.J.; Zhu, G.; Yousufzai, B.; Mian, S.; Khan, S.; Khalifa, Y. Mediation of Cannabidiol Anti-Inflammation in the Retina by Equilibrative Nucleoside Transporter and A2A Adenosine Receptor. Invest Ophthalmol Vis Sci. 2008;49:5526–31.

Posters

Yousufzai, B.; Gasch, A.; Choi, R. Differences in Patient Self-Reported Medication Adherence in a Resident-Directed Glaucoma Clinic. Accepted for presentation at: ASCRS Symposium on Cataract, IOL, and Refractive Surgery, 2017 May 5; Los Angeles, CA.

Kueny, L.; Yousufzai, B.; Levinson, J.; Summerfield, M. The Unusual Case of a Jumping Intraocular Lens Implant. Accepted for presentation at: ASCRS Symposium on Cataract, IOL, and Refractive Surgery, 2017 May 5; Los Angeles, CA.

Yousufzai, B.; Lindsell, L.; Kammel, J.; Lai, M. Retinal Vein Occlusion in Young Patients: Assessing Visual Outcomes and Risk Factors. Poster session presented at: The Annual Meeting of the Association for Research in Vision and Ophthalmology, 2016 May 2; Seattle, WA.

Yousufzai, B.; Lindsell, L.; Kammel, J.; Lai, M. Retinal Vein Occlusion in Young Patients: Assessing Visual Outcomes and Risk Factors. Poster session presented at: Washington Retina Symposium, 2015 Oct 24; Washington, D.C. — Winner of Best Poster Award

Yousufzai, B.; Al-Gayyar, M.; Abdelsaid, M.; Matragoon, S.; Pillai, B.; El-Remessy, A. Role of proNGF in glial activation and neuronal death in diabetic retinopathy. Poster session presented at: Southern Translational Education and Research Conference; 2010 Sept 10-11; Augusta, GA.

Liou, G.; Auchampach, J.; Hillard, C.; Zhu, G.; Yousufzai, B.; Mian, S.; Khan, S.; Khalifa, Y. Mediation of Cannabidiol Immunosuppression by Adenosine Receptor A2a in Retinal Microglia. Poster session presented at: The Annual Conference of the Association for Research in Vision and Ophthalmology; 2008 Apr 27 – May 1; Ft. Lauderdale, FL.

Co-Founder and Executive Board Member, Public Health Interest Group, 2010-11 — Organized lectures on public health topics and coordinated support for local non-smoking ordinance

Mentor, MCG Mentor-Mentee Program, 2010-13

Volunteer, MCG Homeless Clinic, 2010-11

Associate physician at Associates in Ophthalmology Ltd in West Mifflin, Pennsylvania

Traveling, spending time with family and friends